ENTITY
HUTCHMED

HUTCHMED (HCM US)

56
Analysis
Health Care • Hong Kong
HUTCHMED is an innovative, commercial-stage biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing targeted therapies and immunotherapies for cancer and immunological diseases. The company has several novel oncology products marketed in China, with one also approved in the US, Europe, and Japan. HUTCHMED was founded in 2000 and is headquartered in Hong Kong.
more
bullish•HUTCHMED
•11 Aug 2026 08:08

Primer: HUTCHMED (HCM US) - Aug 2026

HUTCHMED is a commercial-stage biopharmaceutical company with a strong focus on oncology, possessing a portfolio of marketed products in China...

Logo
101 Views
Share
x